Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Detection of Precursor Diseases of Multiple Myeloma.
O'Donnell EK, Borden BA, Ghobrial IM. O'Donnell EK, et al. Hematol Oncol Clin North Am. 2024 May 9:S0889-8588(24)00030-3. doi: 10.1016/j.hoc.2024.03.003. Online ahead of print. Hematol Oncol Clin North Am. 2024. PMID: 38724285 Review.
Early Cancer Detection in Focus.
O'Donnell E. O'Donnell E. Hematol Oncol Clin North Am. 2024 May 7:S0889-8588(24)00048-0. doi: 10.1016/j.hoc.2024.04.006. Online ahead of print. Hematol Oncol Clin North Am. 2024. PMID: 38719654 No abstract available.
A Web-Based Peer Support Network to Help Care Partners of People With Serious Illness: Co-Design Study.
O'Donnell EA, Van Citters AD, Khayal IS, Wilson MM, Gustafson D, Barnato AE, Buccellato AC, Young C, Holthoff MM, Korsunskiy E, Tomlin SC, Cullinan AM, Steinbaugh AC, Hinson JJ, Johnson KR, Williams A, Thomson RM, Haines JM, Holmes AB, Bradley AD, Nelson EC, Kirkland KB. O'Donnell EA, et al. JMIR Hum Factors. 2024 May 8;11:e53194. doi: 10.2196/53194. JMIR Hum Factors. 2024. PMID: 38717809 Free PMC article.
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.
Nadeem O, Aranha MP, Redd R, Timonian M, Magidson S, Lightbody ED, Alberge JB, Bertamini L, Dutta AK, El-Khoury H, Bustoros M, Laubach JP, Bianchi G, O'Donnell E, Wu T, Tsuji J, Anderson K, Getz G, Trippa L, Richardson PG, Sklavenitis-Pistofidis R, Ghobrial IM. Nadeem O, et al. Among authors: o donnell e. medRxiv [Preprint]. 2024 Apr 19:2024.04.19.24306082. doi: 10.1101/2024.04.19.24306082. medRxiv. 2024. PMID: 38699307 Free PMC article. Preprint.
Five-Year Mortality Rates Following Elective Shoulder Arthroplasty and Shoulder Arthroplasty for Fracture in Patients Over Age 65.
Khan AZ, Zhang X, Macarayan E, Best MJ, Fedorka CJ, Haas DA, Armstrong AD, Jawa A, O'Donnell EA, Simon JE, Wagner ER, Malik M, Gottschalk MB, Updegrove GF, Warner JJP, Srikumaran U, Abboud JA. Khan AZ, et al. Among authors: o donnell ea. JB JS Open Access. 2024 Apr 29;9(2):e23.00133. doi: 10.2106/JBJS.OA.23.00133. eCollection 2024 Apr-Jun. JB JS Open Access. 2024. PMID: 38685966 Free PMC article.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial.
O'Donnell E, Mo C, Yee AJ, Nadeem O, Laubach J, Rosenblatt J, Munshi N, Midha S, Cirstea D, Chrysafi P, Horick N, Richardson PG, Raje N. O'Donnell E, et al. Lancet Haematol. 2024 Jun;11(6):e415-e424. doi: 10.1016/S2352-3026(24)00070-X. Epub 2024 Apr 24. Lancet Haematol. 2024. PMID: 38677302 Clinical Trial.
339 results